2017 Q1 Form 10-Q Financial Statement
#000156459017008745 Filed on May 04, 2017
Income Statement
| Concept | 2017 Q1 | 2016 Q1 |
|---|---|---|
| Revenue | $7.006M | $7.632M |
| YoY Change | -8.2% | -0.78% |
| Cost Of Revenue | $3.694M | $4.263M |
| YoY Change | -13.35% | -9.57% |
| Gross Profit | $3.312M | $3.369M |
| YoY Change | -1.69% | 13.13% |
| Gross Profit Margin | 47.27% | 44.14% |
| Selling, General & Admin | $13.68M | $11.75M |
| YoY Change | 16.48% | 0.25% |
| % of Gross Profit | 413.13% | 348.68% |
| Research & Development | $9.150M | $6.917M |
| YoY Change | 32.28% | 23.94% |
| % of Gross Profit | 276.27% | 205.31% |
| Depreciation & Amortization | $469.0K | $476.0K |
| YoY Change | -1.47% | 7.45% |
| % of Gross Profit | 14.16% | 14.13% |
| Operating Expenses | $22.83M | $18.71M |
| YoY Change | 22.01% | 7.87% |
| Operating Profit | -$18.09M | -$15.35M |
| YoY Change | 17.91% | 6.78% |
| Interest Expense | $531.0K | $655.0K |
| YoY Change | -18.93% | 156.86% |
| % of Operating Profit | ||
| Other Income/Expense, Net | -$470.0K | -$706.0K |
| YoY Change | -33.43% | -114.32% |
| Pretax Income | -$18.56M | -$16.05M |
| YoY Change | 15.65% | 70.01% |
| Income Tax | $35.00K | $812.0K |
| % Of Pretax Income | ||
| Net Earnings | -$18.60M | -$16.86M |
| YoY Change | 10.29% | 78.26% |
| Net Earnings / Revenue | -265.46% | -220.95% |
| Basic Earnings Per Share | -$0.18 | -$0.17 |
| Diluted Earnings Per Share | -$0.18 | -$0.17 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 103.6M | 99.47M |
| Diluted Shares Outstanding | 103.6M | 99.47M |
Balance Sheet
| Concept | 2017 Q1 | 2016 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $53.80M | $91.30M |
| YoY Change | -41.08% | -18.41% |
| Cash & Equivalents | $11.19M | $20.79M |
| Short-Term Investments | $42.80M | $70.51M |
| Other Short-Term Assets | $3.461M | $6.333M |
| YoY Change | -45.35% | 227.63% |
| Inventory | $12.90M | $11.26M |
| Prepaid Expenses | $1.377M | |
| Receivables | $5.600M | $4.086M |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $75.72M | $119.4M |
| YoY Change | -36.6% | -12.45% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $2.842M | $3.380M |
| YoY Change | -15.92% | -10.98% |
| Goodwill | $1.316M | $1.316M |
| YoY Change | 0.0% | 0.0% |
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $4.113M | $2.341M |
| YoY Change | 75.69% | 1572.14% |
| Total Long-Term Assets | $9.221M | $8.501M |
| YoY Change | 8.47% | 24.9% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $75.72M | $119.4M |
| Total Long-Term Assets | $9.221M | $8.501M |
| Total Assets | $84.94M | $127.9M |
| YoY Change | -33.61% | -10.67% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $8.789M | $6.238M |
| YoY Change | 40.89% | -40.65% |
| Accrued Expenses | $9.492M | $9.221M |
| YoY Change | 2.94% | 29.8% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $7.700M | $4.500M |
| YoY Change | 71.11% | 650.0% |
| Total Short-Term Liabilities | $26.44M | $22.82M |
| YoY Change | 15.89% | 0.24% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $10.50M | $15.30M |
| YoY Change | -31.37% | 64.52% |
| Other Long-Term Liabilities | $1.622M | $1.314M |
| YoY Change | 23.44% | 17.74% |
| Total Long-Term Liabilities | $1.622M | $1.314M |
| YoY Change | 23.44% | 17.74% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $26.44M | $22.82M |
| Total Long-Term Liabilities | $1.622M | $1.314M |
| Total Liabilities | $43.45M | $44.40M |
| YoY Change | -2.14% | 33.39% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$679.3M | -$614.7M |
| YoY Change | 10.52% | 11.47% |
| Common Stock | $720.9M | $694.8M |
| YoY Change | 3.76% | 5.06% |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $41.49M | $83.53M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $84.94M | $127.9M |
| YoY Change | -33.61% | -10.67% |
Cashflow Statement
| Concept | 2017 Q1 | 2016 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$18.60M | -$16.86M |
| YoY Change | 10.29% | 78.26% |
| Depreciation, Depletion And Amortization | $469.0K | $476.0K |
| YoY Change | -1.47% | 7.45% |
| Cash From Operating Activities | -$16.35M | -$13.04M |
| YoY Change | 25.38% | -17.21% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $185.0K | $43.00K |
| YoY Change | 330.23% | -27.12% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $5.860M | -$45.04M |
| YoY Change | -113.01% | -31.28% |
| Cash From Investing Activities | $5.680M | -$45.09M |
| YoY Change | -112.6% | -31.25% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | $7.199M | |
| YoY Change | -90.47% | |
| Debt Paid & Issued, Net | $1.271M | $32.00K |
| YoY Change | 3871.88% | 14.29% |
| Cash From Financing Activities | -880.0K | 7.870M |
| YoY Change | -111.18% | -89.71% |
| NET CHANGE | ||
| Cash From Operating Activities | -16.35M | -13.04M |
| Cash From Investing Activities | 5.680M | -45.09M |
| Cash From Financing Activities | -880.0K | 7.870M |
| Net Change In Cash | -11.55M | -50.26M |
| YoY Change | -77.02% | 938.43% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$16.35M | -$13.04M |
| Capital Expenditures | $185.0K | $43.00K |
| Free Cash Flow | -$16.54M | -$13.08M |
| YoY Change | 26.39% | -17.24% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2016Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
3078000 | |
| CY2017Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
41487000 | |
| CY2016Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
149000 | |
| CY2016Q4 | us-gaap |
Secured Long Term Debt
SecuredLongTermDebt
|
12441000 | |
| CY2016Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
11747000 | |
| CY2016Q4 | us-gaap |
Secured Debt Current
SecuredDebtCurrent
|
6934000 | |
| CY2017Q1 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
470000 | |
| CY2017Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
26444000 | |
| CY2016Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
26888000 | |
| CY2016Q4 | cers |
Accrual For Manufacturing And Development Payment Liability Noncurrent
AccrualForManufacturingAndDevelopmentPaymentLiabilityNoncurrent
|
4770000 | |
| CY2016Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
1590000 | |
| CY2016Q4 | us-gaap |
Liabilities
Liabilities
|
45689000 | |
| CY2016Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2016Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
103000 | |
| CY2016Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
718299000 | |
| CY2016Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
103000 | |
| CY2016Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-660718000 | |
| CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
57787000 | |
| CY2016Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
103476000 | |
| CY2017Q1 | us-gaap |
Gross Profit
GrossProfit
|
3312000 | |
| CY2016Q1 | us-gaap |
Gross Profit
GrossProfit
|
3369000 | |
| CY2017Q1 | us-gaap |
Contracts Revenue
ContractsRevenue
|
1428000 | |
| CY2017Q1 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
9150000 | |
| CY2016Q1 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
6917000 | |
| CY2017Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
13633000 | |
| CY2017Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
50000 | |
| CY2016Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
50000 | |
| CY2017Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
22833000 | |
| CY2017Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-18093000 | |
| CY2017Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-45000 | |
| CY2017Q1 | us-gaap |
Interest Expense
InterestExpense
|
531000 | |
| CY2017Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
106000 | |
| CY2017Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-470000 | |
| CY2016Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-706000 | |
| CY2017Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-18563000 | |
| CY2017Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
35000 | |
| CY2017Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-18598000 | |
| CY2017Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.18 | |
| CY2017Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.18 | |
| CY2017Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
103564000 | |
| CY2017Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
103564000 | |
| CY2017Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-246000 | |
| CY2017Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-18844000 | |
| CY2017Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
0 | |
| CY2016Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
-2058000 | |
| CY2017Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
469000 | |
| CY2016Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
476000 | |
| CY2017Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2147000 | |
| CY2016Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1776000 | |
| CY2017Q1 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
262000 | |
| CY2017Q1 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
3694000 | |
| CY2017Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2842000 | |
| CY2017Q1 | us-gaap |
Goodwill
Goodwill
|
1316000 | |
| CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
738000 | |
| CY2016Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2985000 | |
| CY2017Q1 | us-gaap |
Assets Current
AssetsCurrent
|
75720000 | |
| CY2016Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
4148000 | |
| CY2016Q4 | us-gaap |
Assets
Assets
|
103476000 | |
| CY2016Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
8587000 | |
| CY2016Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
11218000 | |
| CY2016Q4 | us-gaap |
Assets Current
AssetsCurrent
|
94105000 | |
| CY2016Q4 | us-gaap |
Goodwill
Goodwill
|
1316000 | |
| CY2016Q4 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
184000 | |
| CY2017Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2017Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-143000 | |
| CY2017Q1 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
7006000 | |
| CY2017Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
103000 | |
| CY2017Q1 | us-gaap |
Secured Long Term Debt
SecuredLongTermDebt
|
10464000 | |
| CY2017Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
8789000 | |
| CY2017Q1 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
3461000 | |
| CY2017Q1 | us-gaap |
Liabilities
Liabilities
|
43454000 | |
| CY2017Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-679316000 | |
| CY2017Q1 | cers |
Accrual For Manufacturing And Development Payment Liability Noncurrent
AccrualForManufacturingAndDevelopmentPaymentLiabilityNoncurrent
|
4924000 | |
| CY2017Q1 | us-gaap |
Secured Debt Current
SecuredDebtCurrent
|
7693000 | |
| CY2017Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
1622000 | |
| CY2017Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
720843000 | |
| CY2017Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
9492000 | |
| CY2017Q1 | us-gaap |
Assets
Assets
|
84941000 | |
| CY2017Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
688000 | |
| CY2017Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
4113000 | |
| CY2016Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-15345000 | |
| CY2016Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-117000 | |
| CY2016Q1 | us-gaap |
Interest Expense
InterestExpense
|
655000 | |
| CY2016Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
66000 | |
| CY2016Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
18714000 | |
| CY2016Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-16051000 | |
| CY2016Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
812000 | |
| CY2016Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-16863000 | |
| CY2016Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.17 | |
| CY2016Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.17 | |
| CY2016Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
99471000 | |
| CY2016Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
99471000 | |
| CY2016Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-3922000 | |
| CY2016Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-20785000 | |
| CY2017Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
84941000 | |
| CY2016Q1 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
7632000 | |
| CY2016Q1 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
4263000 | |
| CY2017Q1 | cers |
Non Cash Interest Expense
NonCashInterestExpense
|
195000 | |
| CY2016Q1 | cers |
Non Cash Interest Expense
NonCashInterestExpense
|
300000 | |
| CY2017Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
7000 | |
| CY2016Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
9000 | |
| CY2016Q1 | cers |
Non Cash Tax Expense Benefit From Other Unrealized Gain Loss On Available For Sale Securities
NonCashTaxExpenseBenefitFromOtherUnrealizedGainLossOnAvailableForSaleSecurities
|
768000 | |
| CY2017Q1 | us-gaap |
Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
|
18000 | |
| CY2017Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1285000 | |
| CY2016Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1708000 | |
| CY2017Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
388000 | |
| CY2016Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
488000 | |
| CY2017Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
310000 | |
| CY2016Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
213000 | |
| CY2017Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
198000 | |
| CY2016Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
995000 | |
| CY2017Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-1724000 | |
| CY2016Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-639000 | |
| CY2017Q1 | cers |
Increase Decrease In Manufacturing And Development Payment Liability
IncreaseDecreaseInManufacturingAndDevelopmentPaymentLiability
|
76000 | |
| CY2016Q1 | cers |
Increase Decrease In Manufacturing And Development Payment Liability
IncreaseDecreaseInManufacturingAndDevelopmentPaymentLiability
|
-924000 | |
| CY2017Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
313000 | |
| CY2016Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
52000 | |
| CY2017Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-16348000 | |
| CY2016Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-13043000 | |
| CY2017Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
185000 | |
| CY2016Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
43000 | |
| CY2017Q1 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
10158000 | |
| CY2016Q1 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
50544000 | |
| CY2017Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
16018000 | |
| CY2016Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
5500000 | |
| CY2017Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
5675000 | |
| CY2016Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-45087000 | |
| CY2017Q1 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
422000 | |
| CY2016Q1 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
698000 | |
| CY2017Q1 | cers |
Payments For Proceeds From Issuance Of Common Stock
PaymentsForProceedsFromIssuanceOfCommonStock
|
30000 | |
| CY2016Q1 | cers |
Payments For Proceeds From Issuance Of Common Stock
PaymentsForProceedsFromIssuanceOfCommonStock
|
-7199000 | |
| CY2017Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
1271000 | |
| CY2016Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
32000 | |
| CY2017Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
-879000 | |
| CY2016Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
7865000 | |
| CY2017Q1 | cers |
Cash Cash Equivalents And Restricted Cash Period Increase Decrease
CashCashEquivalentsAndRestrictedCashPeriodIncreaseDecrease
|
-11552000 | |
| CY2016Q1 | cers |
Cash Cash Equivalents And Restricted Cash Period Increase Decrease
CashCashEquivalentsAndRestrictedCashPeriodIncreaseDecrease
|
-50265000 | |
| CY2016Q4 | cers |
Cash Cash Equivalents And Restricted Cash At Carrying Value
CashCashEquivalentsAndRestrictedCashAtCarryingValue
|
22744000 | |
| CY2015Q4 | cers |
Cash Cash Equivalents And Restricted Cash At Carrying Value
CashCashEquivalentsAndRestrictedCashAtCarryingValue
|
71630000 | |
| CY2017Q1 | cers |
Cash Cash Equivalents And Restricted Cash At Carrying Value
CashCashEquivalentsAndRestrictedCashAtCarryingValue
|
11192000 | |
| CY2016Q1 | cers |
Cash Cash Equivalents And Restricted Cash At Carrying Value
CashCashEquivalentsAndRestrictedCashAtCarryingValue
|
21365000 | |
| CY2017Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements requires management to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, management evaluates its estimates, including those related to the accounts receivable, inventory reserves, fair values of investments, stock-based compensation, intangible assets and goodwill, useful lives of intangible assets and property and equipment, income taxes, and accrued liabilities, among others. The Company bases its estimates on historical experience, future projections, and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from those estimates under different assumptions or conditions.</p></div> | |
| CY2017Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, available-for-sale securities and accounts receivable.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the Company’s investment policy, substantially all of the Company’s cash, cash equivalents and available-for-sale securities are maintained at major financial institutions of high credit standing. The Company monitors the financial credit worthiness of the issuers of its investments and limits the concentration in individual securities and types of investments that exist within its investment portfolio. Generally, all of the Company’s investments carry high credit quality ratings, which is in accordance with its investment policy. At March 31, 2017, the fair value of the Company’s marketable equity securities of Aduro is subject to the underlying volatility of Aduro’s stock price. At March 31, 2017, the Company does not believe there is significant financial risk from non-performance by the issuers of the Company’s cash equivalents and short-term investments.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Concentrations of credit risk with respect to trade receivables exist. On a regular basis, including at the time of sale, the Company performs credit evaluations of its significant customers that it expects to sell to on credit terms. Generally, the Company does not require collateral from its customers to secure accounts receivable. To the extent that the Company determines specific invoices or customer accounts may be uncollectible, the Company establishes an allowance for doubtful accounts against the accounts receivable on its unaudited condensed consolidated balance sheets and records a charge on its unaudited condensed consolidated statements of operations as a component of selling, general and administrative expenses.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company had three customers that accounted for more than 10% of the Company’s outstanding trade receivables at March 31, 2017 and December 31, 2016. These customers cumulatively represented approximately 39% and 46% of the Company’s outstanding trade receivables at March 31, 2017 and December 31, 2016, respectively. To date, the Company has not experienced collection difficulties from these customers.</p></div> | |
| CY2017Q1 | us-gaap |
Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
|
<div> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Guarantee and Indemnification Arrangements</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes the fair value for guarantee and indemnification arrangements issued or modified by the Company. In addition, the Company monitors the conditions that are subject to the guarantees and indemnifications in order to identify if a loss has occurred. If the Company determines it is probable that a loss has occurred, then any such estimable loss would be recognized under those guarantees and indemnifications. Some of the agreements that the Company is a party to contain provisions that indemnify the counter party from damages and costs resulting from claims that the Company’s technology infringes the intellectual property rights of a third party or claims that the sale or use of the Company’s products have caused personal injury or other damage or loss. The Company has not received any such requests for indemnification under these provisions and has not been required to make material payments pursuant to these provisions.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company generally provides for a one-year warranty on certain of its INTERCEPT blood-safety products covering defects in materials and workmanship. The Company accrues costs associated with warranty obligations when claims become known and are estimable. The Company has not experienced significant or systemic warranty claims nor is it aware of any existing current warranty claims. Accordingly, the Company had not accrued for any future warranty costs for its products at March 31, 2017 and December 31, 2016.</p></div> | |
| CY2017Q1 | cers |
Cumulative Outstanding Trade Receivables Number Of Major Customers
CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers
|
3 | |
| CY2016Q4 | cers |
Cumulative Outstanding Trade Receivables Number Of Major Customers
CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers
|
3 | |
| CY2017Q1 | cers |
Inventory Life Finished Goods Period
InventoryLifeFinishedGoodsPeriod
|
P2Y | |
| CY2017Q1 | cers |
Work In Process Inventory Life Period
WorkInProcessInventoryLifePeriod
|
P1Y | |
| CY2017Q1 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
200000 | |
| CY2016Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
200000 | |
| CY2017Q1 | us-gaap |
Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
|
P10Y | |
| CY2017Q1 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | |
| CY2017Q1 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | |
| CY2016Q1 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | |
| CY2017Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
17675000 | |
| CY2016Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
15022000 | |
| CY2017Q1 | cers |
Product Warranty Term
ProductWarrantyTerm
|
P1Y | |
| CY2017Q1 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
0 | |
| CY2016Q4 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
0 | |
| CY2017Q1 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
40252000 | |
| CY2017Q1 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
3710000 | |
| CY2017Q1 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
28000 | |
| CY2017Q1 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
43934000 | |
| CY2016Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
54131000 | |
| CY2016Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
3952000 | |
| CY2016Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
24000 | |
| CY2016Q4 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
58059000 | |
| CY2017Q1 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
|
40252000 | |
| CY2016Q4 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
|
54131000 | |
| CY2017Q1 | us-gaap |
Available For Sale Equity Securities Amortized Cost Basis
AvailableForSaleEquitySecuritiesAmortizedCostBasis
|
0 | |
| CY2016Q4 | us-gaap |
Available For Sale Equity Securities Amortized Cost Basis
AvailableForSaleEquitySecuritiesAmortizedCostBasis
|
0 | |
| CY2017Q1 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
40224000 | |
| CY2016Q4 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
54107000 | |
| CY2017Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
|
36118000 | |
| CY2016Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
|
40121000 | |
| CY2017Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
28000 | |
| CY2016Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
24000 | |
| CY2017Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
|
36118000 | |
| CY2016Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
|
40121000 | |
| CY2017Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
|
28000 | |
| CY2016Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
|
24000 | |
| CY2017Q1 | us-gaap |
Impairment Of Investments
ImpairmentOfInvestments
|
0 | |
| CY2016Q1 | us-gaap |
Impairment Of Investments
ImpairmentOfInvestments
|
0 | |
| CY2017Q1 | us-gaap |
Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
|
20000 | |
| CY2017Q1 | us-gaap |
Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
|
0 | |
| CY2016Q1 | us-gaap |
Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
|
0 | |
| CY2017Q1 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
4409000 | |
| CY2016Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
5044000 | |
| CY2017Q1 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
8510000 | |
| CY2016Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
7487000 | |
| CY2017Q1 | us-gaap |
Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
|
0 | |
| CY2017Q1 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | |
| CY2017Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
2017000 | |
| CY2017Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
1329000 | |
| CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
2017000 | |
| CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
1279000 | |
| CY2017Q1 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | |
| CY2016Q1 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | |
| CY2017Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
150000 | |
| CY2017Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
200000 | |
| CY2017Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
200000 | |
| CY2017Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
100000 | |
| CY2017Q1 | us-gaap |
Cost Method Investments
CostMethodInvestments
|
0 | |
| CY2017Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
4647000 | |
| CY2016Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
7098000 | |
| CY2017Q1 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
3450000 | |
| CY2016Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
2511000 | |
| CY2017Q1 | cers |
Accrued Customer Costs Current
AccruedCustomerCostsCurrent
|
556000 | |
| CY2016Q4 | cers |
Accrued Customer Costs Current
AccruedCustomerCostsCurrent
|
534000 | |
| CY2017Q1 | us-gaap |
Accrued Insurance Current
AccruedInsuranceCurrent
|
238000 | |
| CY2016Q4 | us-gaap |
Accrued Insurance Current
AccruedInsuranceCurrent
|
476000 | |
| CY2017Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
601000 | |
| CY2016Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
599000 | |
| CY2017Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
|
5771000 | |
| CY2017Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
8178000 | |
| CY2017Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
|
4308000 | |
| CY2017Q1 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
18257000 | |
| CY2017Q1 | cers |
Longterm Debt Maturities Repayments Of Interest In Next Twelve Months
LongtermDebtMaturitiesRepaymentsOfInterestInNextTwelveMonths
|
823000 | |
| CY2017Q1 | cers |
Long Term Debt Maturities Repayments Of Interest In Year Two
LongTermDebtMaturitiesRepaymentsOfInterestInYearTwo
|
613000 | |
| CY2017Q1 | cers |
Long Term Debt Maturities Repayments Of Interest In Year Three
LongTermDebtMaturitiesRepaymentsOfInterestInYearThree
|
1488000 | |
| CY2017Q1 | cers |
Long Term Debt Maturities Repayments Of Interest
LongTermDebtMaturitiesRepaymentsOfInterest
|
2924000 | |
| CY2017Q1 | cers |
Long Term Debt Maturities Repayments Of Principal And Interest In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInNextTwelveMonths
|
6594000 | |
| CY2017Q1 | cers |
Long Term Debt Maturities Repayments Of Principal And Interest In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearTwo
|
8791000 | |
| CY2017Q1 | cers |
Long Term Debt Maturities Repayments Of Principal And Interest In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearThree
|
5796000 | |
| CY2017Q1 | cers |
Long Term Debt Maturities Repayments Of Principal And Interest
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterest
|
21181000 | |
| CY2017Q1 | cers |
Minimum Term Of Non Cancelable Operating Leases
MinimumTermOfNonCancelableOperatingLeases
|
P1Y | |
| CY2017Q1 | cers |
Expiration Of Non Cancelable Operating Leases Maximum Year
ExpirationOfNonCancelableOperatingLeasesMaximumYear
|
2021 | |
| CY2010 | cers |
Proceeds From Landlord Financing Leasehold Improvement
ProceedsFromLandlordFinancingLeaseholdImprovement
|
1100000 | |
| CY2017Q1 | cers |
Accrued Leasehold Improvements Current And Accrued Leasehold Improvements Noncurrent
AccruedLeaseholdImprovementsCurrentAndAccruedLeaseholdImprovementsNoncurrent
|
300000 | |
| CY2017Q1 | cers |
Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
|
3200000 | |
| CY2016Q1 | cers |
Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
|
3600000 | |
| CY2017Q1 | us-gaap |
Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
|
900000 | |
| CY2016Q4 | us-gaap |
Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
|
300000 | |
| CY2017Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 |
